Northern Ireland has enacted a permanent ban on puberty blockers for individuals under 18 seeking sex change treatments.
The decision follows a series of temporary measures, beginning with an emergency ban in May to halt prescriptions of puberty blockers to minors. This ban was extended in August and has now been made indefinite after a government vote.
According to the BBC, the ban will be part of a wider announcement that is due in other parts of the UK later this week. Deputy First Minister Emma Little-Pengelly wrote on X that the ban was “the right approach, informed by medical and scientific advice.”
"The protection and safety of our young people must be paramount,” she added.
Not all officials support the move. Green Party Councillor Anthony Flynn criticized the decision, arguing that the government had failed LGBTQ+ communities. "When this temporary ban was announced in the summer, we and many activists argued that the executive should release the evidence that informed this decision. Now that the ban has been made indefinite, it should be released," he said.
Before the initial ban, puberty blockers in Northern Ireland were available only through NHS prescriptions for minors under the Child and Adolescent Mental Health Services (CAMHS) Gender Identity Service endocrine pathway. Those who were already on the pathway before March 2020 will presumably continue to receive puberty blockers.
The decision comes amid the findings revealed in the Cass Review, a comprehensive report led by pediatrician Dr. Hilary Cass, which highlighted significant “gaps in evidence” surrounding the safety and effectiveness of puberty blockers for children. The review’s findings were pivotal in influencing the government’s choice to restrict such treatments for minors who identify as transgender.
